Current Topics in SARS-CoV-2/COVID-19
Two Years After
Seiten
2023
IntechOpen (Verlag)
978-1-80356-233-9 (ISBN)
IntechOpen (Verlag)
978-1-80356-233-9 (ISBN)
- Titel nicht im Sortiment
- Artikel merken
The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has probably been the most important disease to emerge in the 21st century. This viral zoonotic disease has been a significant cause of morbidity and mortality worldwide, but with a higher impact in low- and middle-income countries of Africa, Asia, and Latin America. Up to December 4, 2022, more than 645,195,564 cases had been reported globally, with 6,640,845 deaths, and more than 13,054,668,703 doses of a vaccine had been given. Research has been of the utmost importance in the COVID-19 crisis: a great deal of knowledge was gathered between December 2019 and December 2022. Appropriate evidence-based management and the development of safe and effective vaccines have been key to controlling the virus. This book presents a selection of the last two years’ learning from research and clinical practice concerning SARS-CoV-2/COVID-19.
| Erscheinungsdatum | 21.06.2023 |
|---|---|
| Reihe/Serie | Infectious Diseases |
| Verlagsort | London |
| Sprache | englisch |
| Maße | 180 x 260 mm |
| Themenwelt | Studium ► Querschnittsbereiche ► Epidemiologie / Med. Biometrie |
| ISBN-10 | 1-80356-233-1 / 1803562331 |
| ISBN-13 | 978-1-80356-233-9 / 9781803562339 |
| Zustand | Neuware |
| Informationen gemäß Produktsicherheitsverordnung (GPSR) | |
| Haben Sie eine Frage zum Produkt? |
Mehr entdecken
aus dem Bereich
aus dem Bereich
Health Information for International Travel
Buch | Softcover (2025)
Oxford University Press Inc (Verlag)
CHF 85,50
ein überfälliges Gespräch zu einer Pandemie, die nicht die letzte …
Buch | Hardcover (2024)
Ullstein Buchverlage
CHF 34,95